SANOFI S.A. revenue for the last year amounted to 41.64 B CHF, the most of which — 38.62 B CHF — came from its highest performing source at the moment, Biopharma, the year earlier bringing 35.21 B CHF. The greatest contribution to the revenue figure was made by United States — last year it brought SANOFI S.A. 18.79 B CHF, and the year before that — 17.20 B CHF.